EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Dual TYK2/JAK1 Inhibition by Brepocitinib Suppresses TNF-α–Driven Oxidative Stress, PI3K/AKT/mTOR Activation and FAK-Dependent Migration in Rheumatoid Arthritis Synoviocytes

Hai-Ming Huang, Min Tu, Min Ma, Chen Huang

Acta Poloniae Pharmaceutica - Drug Research · 03.03.2026 · 82 (5) · 769-782

DOI: 10.32383/appdr/217369 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Poloniae Pharmaceutica - Drug Research, online erschienen am 03.03.2026. Verfasst von Hai-Ming Huang und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Rheumatoid arthritis (RA) synoviocytes acquire pathogenic phenotype characterized by oxidative stress, sustained activation of pro-survival signaling, enhanced migration, and excessive production of inflammatory mediators. Brepocitinib, a dual TYK2/JAK1 inhibitor, has demonstrated immunomodulatory activity; however, its effects on TNF-α–driven redox imbalance, kinase signaling, and migratory behavior in RA synoviocytes remain incompletely defined.

Methods

Human RA synoviocytes were stimulated with TNF-α (10 ng/mL) and treated with brepocitinib (1–5 µM). Intracellular reactive oxygen species (ROS) were quantified using DCFDA fluorescence. Nrf2–Keap1 antioxidant signaling was examined by nuclear and cytosolic fractionation followed by immunoblotting for Nrf2, Keap1, HO-1, and NQO1. Activation of PI3K–AKT–mTOR and focal adhesion kinase (FAK)–associated cytoskeletal signaling was assessed by immunoblotting for phosphorylated PI3K, AKT (Ser473), mTOR (Ser2448), FAK (Y397), and cofilin. Cell migration was evaluated using a scratch wound-healing assay. Inflammatory responses were analyzed by qRT-PCR and ELISA for cytokines, chemokines, and matrix metalloproteinases, and correlation analysis was performed between ROS and IL-6 expression.

Results

TNF-α markedly increased intracellular ROS and disrupted antioxidant defenses by suppressing nuclear Nrf2, elevating Keap1, and downregulating HO-1 and NQO1. Brepocitinib dose-dependently reduced ROS accumulation and restored Nrf2-dependent antioxidant signaling. TNF-α–induced activation of PI3K–AKT–mTOR and FAK pathways and synoviocyte migration were significantly attenuated by brepocitinib. In parallel, brepocitinib suppressed TNF-α–induced expression and secretion of IL-6, TNF-α, chemokines, and matrix metalloproteinases. ROS levels showed a strong positive correlation with IL-6 expression.

Conclusion

Brepocitinib reprograms TNF-α–activated RA synoviocytes by restoring antioxidant defenses, suppressing survival and migratory signaling, limiting inflammatory amplification and pathogenic synoviocyte behavior in RA.

Zitieren

APA

Huang, H., Tu, M., Ma, M., & Huang, C. (2026). Dual TYK2/JAK1 Inhibition by Brepocitinib Suppresses TNF-α–Driven Oxidative Stress, PI3K/AKT/mTOR Activation and FAK-Dependent Migration in Rheumatoid Arthritis Synoviocytes. Acta Poloniae Pharmaceutica - Drug Research, 82(5), 769-782. https://doi.org/10.32383/appdr/217369

Vancouver

Huang H, Tu M, Ma M, Huang C. Dual TYK2/JAK1 Inhibition by Brepocitinib Suppresses TNF-α–Driven Oxidative Stress, PI3K/AKT/mTOR Activation and FAK-Dependent Migration in Rheumatoid Arthritis Synoviocytes. Acta Poloniae Pharmaceutica - Drug Research. 2026;82(5):769-782. doi:10.32383/appdr/217369

BibTeX
@article{Huang2026,
  author = {Huang, Hai-Ming and Tu, Min and Ma, Min and Huang, Chen},
  title = {Dual TYK2/JAK1 Inhibition by Brepocitinib Suppresses TNF-α–Driven Oxidative Stress, PI3K/AKT/mTOR Activation and FAK-Dependent Migration in Rheumatoid Arthritis Synoviocytes},
  journal = {Acta Poloniae Pharmaceutica - Drug Research},
  year = {2026},
  volume = {82},
  number = {5},
  pages = {769--782},
  doi = {10.32383/appdr/217369}
}
Kostenlos starten →